June 7, 2021 Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis read more
June 2, 2021 Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42 Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report read more
April 28, 2021 Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021 read more
April 22, 2021 Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer’s Disease read more